Benchmark initiated coverage of Know Labs with a Speculative Buy rating and $1 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on KNW: Know Labs to present clinical research at 2024 American Physiology Summit Know Labs files to sell 10.8M shares of common stock for holders Know Labs Reports Promising Results from Clinical Study Know Labs Reveals KnowU for Non-Invasive Glucose Monitoring